MIRALOCK Trademark
Trademark Overview
On Tuesday, January 20, 2026, a trademark application was filed for MIRALOCK with the United States Patent and Trademark Office. The USPTO has given the MIRALOCK trademark a serial number of 99605203. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, May 26, 2026. This trademark is owned by Mirador Therapeutics, Inc.. The MIRALOCK trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; Pharmaceutical research and development of pharmaceutical preparations; Research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; Laboratory research services in connection with developing new medicinal products; Scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics
Pharmaceutical preparations for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Diagnostic preparations for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; Chemical, biological and biochemical reagents for medical or veterinary purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents
Chemical substances, chemical materials and chemical preparations for scientific purposes; Active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines
General Information
| Serial Number | 99605203 |
| Word Mark | MIRALOCK |
| Filing Date | Tuesday, January 20, 2026 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 16, 2026 |
Trademark Statements
| Goods and Services | Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; Pharmaceutical research and development of pharmaceutical preparations; Research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; Laboratory research services in connection with developing new medicinal products; Scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics |
| Goods and Services | Pharmaceutical preparations for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Diagnostic preparations for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; Chemical, biological and biochemical reagents for medical or veterinary purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents |
| Pseudo Mark | MIRA LOCK |
| Goods and Services | Chemical substances, chemical materials and chemical preparations for scientific purposes; Active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 20, 2026 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 20, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 20, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Mirador Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121
US |
Trademark Events
| Event Date | Event Description |
| Tuesday, January 20, 2026 | NEW APPLICATION ENTERED |
| Tuesday, January 20, 2026 | APPLICATION FILING RECEIPT MAILED |
| Thursday, April 2, 2026 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, April 2, 2026 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, April 2, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Saturday, May 9, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 18, 2026 | ASSIGNED TO EXAMINER |
| Tuesday, May 19, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
